Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology, which enables the oral administration of biologic therapeutics. This groundbreaking approach not only enhances patient adherence but also aligns with the growing preference for non-invasive treatment options. With a robust and diversified pipeline targeting multiple therapeutic areas, Rani Therapeutics is strategically positioned for significant growth. The company’s commitment to cutting-edge research and development, along with key partnerships, further underscores its potential to make impactful advancements in the pharmaceutical sector.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$0.84
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 6, 2026 | $-0.05 | $-0.04 | Beat +20.0% | $-0.04 | $925K | $1.71M | +84.9% | 1D Pre-4.9% | On-Day+0.1% | 1D Post+1.4% |
Q ended Mar 31, 2026 Reported May 15, 2026 | $-0.04 | $-0.04 | Met 0.0% | $-0.04 | $500K | $1.71M | +242.0% | 1D Pre+5.7% | On-Day-2.7% | 1D Post-10.0% |
Q ended Dec 31, 2025 Reported Mar 26, 2026 | $-0.04 | $-0.07 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $5M |
| $1.46M |
| -70.8% |
| 1D Pre+7.5% |
| On-Day-5.3% |
| 1D Post-24.9% |
Q ended Sep 30, 2025 Reported Nov 6, 2025 | $-0.17 | $-0.12 | Beat +29.4% | — | $0 | $0 | — | 1D Pre+5.0% | On-Day-9.2% | 1D Post-11.0% |